Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 12,600 | 9,514 | 6,523 | 7,389 | 9,971 |
| Cost of Goods | 8,130 | 7,920 | 5,490 | 6,020 | 5,390 |
| Gross Profit | 4,530 | 1,580 | 1,020 | 1,360 | 4,610 |
| Operating Expenses | 13,360 | 10,740 | 9,480 | 8,660 | 9,210 |
| Operating Income | -8,760 | -8,226 | -7,957 | -7,271 | -4,239 |
| Interest Expense | 0 | 0 | 0 | 0 | 20 |
| Other Income | 1,500 | 9,296 | -2,603 | -1,939 | 1,519 |
| Pre-tax Income | -7,260 | 1,070 | -10,560 | -9,210 | -2,740 |
| Income Tax | 260 | 0 | 0 | 840 | 0 |
| Net Income Continuous | -7,500 | 1,078 | -10,569 | -10,057 | -2,741 |
| Net Income | $-7,500 | $1,078 | $-10,569 | $-10,057 | $-2,741 |
| EPS Basic Total Ops | -4,199.16 | 599.88 | -7,198.56 | -7,198.56 | -1,799.64 |
| EPS Basic Continuous Ops | -4,166.67 | 673.75 | -7,046.00 | -7,183.57 | -1,827.33 |
| EPS Diluted Total Ops | -4,199.16 | 599.88 | -7,198.56 | -7,198.56 | -1,799.64 |
| EPS Diluted Continuous Ops | -4,166.67 | 634.12 | -7,046.00 | -7,183.57 | -1,827.33 |
| EBITDA(a) | $-6,330 | $-8,556 | $-7,547 | $-6,911 | $-8,409 |